HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of topical ophthalmic prophylaxis in prevention of ophthalmia neonatorum.

Abstract
Ophthalmia neonatorum is a form of conjunctivitis occurring in infants younger than 4 weeks. It can be a leading cause of blindness in newborns. In this random clinical case-control study, ophthalmia neonatorum was investigated in one university centre. In this study, prophylactic effect of normal saline and ophthalmic erythromycin was compared with a group not receiving any prophylaxis. The first group received ophthalmic erythromycin ointment (0.5%), the second group were distilled one drop of normal saline into each eye, and the third group did not take any prophylaxis. Within the first 10 days of life, conjunctivitis developed in 138 newborns (13.8%). Of conjunctivitis cases, 29.7% were in erythromycin group, 31.9% in normal saline group and 38.4% were in no-prophylaxis group. In general, no significant difference was observed among the three groups (P > 0.05).
AuthorsZahra Khalili Matinzadeh, Fatemeh Beiragdar, Zohreh Kavemanesh, Hasan Abolgasemi, Susan Amirsalari
JournalTropical doctor (Trop Doct) Vol. 37 Issue 1 Pg. 47-9 (Jan 2007) ISSN: 0049-4755 [Print] England
PMID17326893 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Bacterial Agents
  • Ophthalmic Solutions
  • Erythromycin
Topics
  • Adolescent
  • Adult
  • Anti-Bacterial Agents (administration & dosage, adverse effects)
  • Antibiotic Prophylaxis
  • Erythromycin (administration & dosage, adverse effects)
  • Female
  • Humans
  • Infant, Newborn
  • Male
  • Middle Aged
  • Ophthalmia Neonatorum (prevention & control)
  • Ophthalmic Solutions (administration & dosage, adverse effects)
  • Pregnancy
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: